Company Information

  

Address: 1505 ADAMS DRIVE, SUITE D  
City: MENLO PARK 
State: CA 
Zip Code: 94025 
Telephone: 650-889-5020 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are a specialty pharmaceutical company focused on utilizing our proprietary drug delivery technologies to develop and commercialize novel prescription and over­the­counter, or OTC, products that address large markets in dermatology and women's health. Our objective is to develop products that treat health or age­related conditions that: (1) are not presently being addressed or treated or (2) are currently treated with drug therapies or drug delivery approaches that are sub­optimal.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
04/2018-0.13NAN/E
01/2018-0.19NAN/E
10/2017-0.22NAN/E
07/2017-0.30NAN/E
04/2017-0.43NAN/E
01/2017-0.52NAN/E
10/2016-0.56NAN/E
07/2016-0.59NAN/E

Key Financial Ratios and Statistics

FYE: 01/31

Profitability 2018 Leverage 2018
Net Inc/Comm Equity-0.25Total Liab/Total Assets0.37
Net Inc/Total Assets-2.06Total Liab/Inv Cap0.59
Net Inc/Inv Cap-3.26Total Liab/Comm Equity0.05
Pretax Inc/Net Sales-227.92Interest Coverage RatioNA
Net Inc/Net Sales-227.95Curr Debt/EquityNA
Cash Flow/Net Sales-213.52LTD/EquityNA
SG&A/NetSales103.55Total Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables Turnover13.27Quick Ratio2.68
Inventory Turnover10.42Current Ratio2.68
Inventory Day Sales0.07Net Rec/Curr Assets0.00
Net Sales/Work Cap0.01Inv/Curr Assets0.00
Net Sales/PP&E0.67  

Income Statement (Millions)

  4/30/2018 1/31/2018 10/31/2017 7/31/2017
Total Revenues(Net Sales) 0.02 0.02 0.02 0.02
Cost of Goods Sold 0.01 0.22 0.01 0.01
Selling & Admin Exps 2.05 1.96 1.63 1.87
Operating Income -4.36 -3.84 -3.74 -4.27
Interest Exp NA NA NA NA
Pretax Income -4.40 -3.79 -3.71 -3.74
Other Income -0.04 0.05 0.02 0.53
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -4.40 -3.79 -3.71 -3.74

Balance Sheet (Millions)

Assets 4/30/2018 1/31/2018 10/31/2017 7/31/2017
Cash & Short Term Investments 10.93 7.58 1.58 4.47
Receivables - Total 0.01 0.01 0.01 0.00
Inventories - Total 0.01 0.01 0.02 0.02
Total Current Assets 11.28 7.98 2.17 4.96
Net Property, Plant & Equipment 0.16 0.11 0.12 0.12
Total Assets 11.44 8.09 2.45 5.23
Liabilities        
Accounts Payable 3.07 2.98 3.71 3.84
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 3.07 2.98 3.71 3.84
Long-Term Debt NA NA NA NA
Total Liabilities 3.21 3.02 3.78 4.09
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 1.52 1.52
Common Stock 0.19 0.16 0.08 0.08
Retained Earnings -65.68 -61.28 -57.49 -53.78
Treasury Stock NA NA NA NA
Total Stockholders' Equity 8.23 5.07 -1.33 1.15
Total Liabilities and Stockholders' Equity 11.44 8.09 2.45 5.23

Cash Flow Summary (Millions)

Categories 4/30/2018 1/31/2018 10/31/2017 7/31/2017
Net Cash Provided by Operating Activities -3.60 -3.72 -3.49 -4.15
Net Cash Provided by Investing Activities -0.00 0.00 -0.01 -0.02
Net Cash Provided by Financing Activities 6.96 9.72 0.62 1.92

Annual Summary Data (Millions)

Year Sales Net Income EPS
01/20130.00-0.05--
01/20140.00-7.81--
01/20160.06-15.60-0.89
01/20170.10-18.41-0.52
01/20180.07-16.64-0.19
Growth RatesInfinity----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/182733,87817.69




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.